Price$18.13-0.25 (-1.33%)
03:15 PM07:45 PM
News · 26 weeks520%
2026-04-192026-10-11
Mix3190d
- Insider12(39%)
- Other9(29%)
- SEC Filings7(23%)
- Earnings2(6%)
- Analyst1(3%)
Latest news
25 items- PRShoulder Innovations to Report Third Quarter 2026 Financial Results on November 5, 2026GRAND RAPIDS, Mich., Oct. 15, 2026 /PRNewswire/ -- Shoulder Innovations, Inc. ("Shoulder Innovations", or "the company") (NYSE:SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today announced it will release financial results for the third quarter of 2026 after market close on Thursday, November 5, 2026.Management will host a conference call to discuss financial results beginning at 4:30 p.m. ET / 1:30 p.m. PT on November 5, 2026. Those interested in listening to the conference call may do so by dialing (877) 407-8216 for domestic callers or (412) 902-1015 for international callers and providing access code 13762885. A
- SECSEC Form 8-K filed by Shoulder Innovations Inc.8-K - SHOULDER INNOVATIONS, INC. (0001699350) (Filer)
- PRShoulder Innovations Initiates Commercial Launch of the InSet® GoLimited User Release of the Company's Next-Generation InSet® Glenoid Implant Follows Successful Completion of First Surgical Case GRAND RAPIDS, Mich., Oct. 8, 2026 /PRNewswire/ -- Shoulder Innovations, Inc. ("Shoulder Innovations", or "the company") (NYSE:SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today announced it has initiated a limited user release of the InSet® Go, the company's next-generation glenoid implant, for use in anatomic shoulder arthroplasty procedures. The first surgical case utilizing the InSet® Go was performed by Robert Gillespie, MD, of University Hospitals Cleveland Medical Center, Cleveland,
- INSIDERSEC Form 4 filed by Shoulder Innovations Inc.4 - SHOULDER INNOVATIONS, INC. (0001699350) (Issuer)
- INSIDERSEC Form 4 filed by Shoulder Innovations Inc.4 - SHOULDER INNOVATIONS, INC. (0001699350) (Issuer)
- INSIDERSEC Form 4 filed by Shoulder Innovations Inc.4 - SHOULDER INNOVATIONS, INC. (0001699350) (Issuer)
- INSIDERSEC Form 4 filed by Shoulder Innovations Inc.4 - SHOULDER INNOVATIONS, INC. (0001699350) (Issuer)
- INSIDERCEO & Executive Chairman Ball Robert Joseph exercised 89,233 shares at a strike of $2.10 and sold $187,706 worth of shares (10,175 units at $18.45), increasing direct ownership by 26% to 380,824 units (SEC Form 4)4 - SHOULDER INNOVATIONS, INC. (0001699350) (Issuer)
- PRShoulder Innovations Receives FDA 510(k) Clearance for N-22 Humeral Head and Initiates Full Commercial LaunchSecond Product Introduction on New Line of Technologies for Metal-Sensitive PatientsGRAND RAPIDS, Mich., Sept. 10, 2026 /PRNewswire/ -- Shoulder Innovations, Inc. ("Shoulder Innovations", or "the company") (NYSE:SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the N-22 Humeral Head, a titanium implant option for patients with metal hypersensitivity. Alongside the clearance, the company also announced the product's full commercial launch. Approximately 10% to 15% of
- PRShoulder Innovations Announces Exclusive Partnership with ALM Ortho to Introduce Bespoke Solution for Complex Shoulder Reconstruction ProceduresGRAND RAPIDS, Mich., Sept. 9, 2026 /PRNewswire/ -- Shoulder Innovations, Inc. ("Shoulder Innovations", or "the company") (NYSE:SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today announced it has entered into an exclusive collaboration with ALM Ortho, Inc. ("ALM Ortho"), a leader in additive manufacturing of titanium orthopedic implants, to introduce a bespoke implant for the treatment of severe shoulder deformity and other highly complex revision cases, circumstances for which no adequate solution currently exists. Informed by patient imaging data, ALM
- PRShoulder Innovations Announces Settlement of Patent Litigation with Catalyst OrthoScienceGRAND RAPIDS, Mich., Sept. 8, 2026 /PRNewswire/ -- Shoulder Innovations, Inc. ("Shoulder Innovations") (NYSE:SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today announced that it has entered into a settlement agreement with Catalyst OrthoScience Inc. ("Catalyst") to resolve all outstanding patent litigation between the two companies. The terms of the settlement agreement are confidential. "We are pleased to have reached a resolution with Catalyst that provides an agreeable solution to this patent dispute," said Rob Ball, CEO of Shoulder Innovations. "Pr
- PRShoulder Innovations to Participate in the Morgan Stanley 24th Annual Healthcare ConferenceGRAND RAPIDS, Mich., Sept. 1, 2026 /PRNewswire/ -- Shoulder Innovations, Inc. (Shoulder Innovations, or the company) (NYSE:SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today announced that members of management will participate in a fireside chat at the Morgan Stanley 24th Annual Healthcare Conference. The fireside chat will take place at 3:20 p.m. ET / 12:20 p.m. PT on Tuesday, September 15, 2026. A live and archived webcast of the event will be available in the "Investor Relations" section of the Shoulder Innovations website at https://ir.shoulderinn
- INSIDERLarge owner Gilde Healthcare Holding B.V. sold $27,030 worth of shares (1,196 units at $22.60) (SEC Form 4)4 - SHOULDER INNOVATIONS, INC. (0001699350) (Issuer)
- INSIDERLarge owner Gilde Healthcare Holding B.V. sold $567,411 worth of shares (25,097 units at $22.61) (SEC Form 4)4 - SHOULDER INNOVATIONS, INC. (0001699350) (Issuer)
- INSIDERChief Operating Officer Ahearn Matthew Fraser gifted 2,500 shares and sold $464,805 worth of shares (22,500 units at $20.66) as part of a pre-agreed trading plan, decreasing direct ownership by 9% to 244,176 units (SEC Form 4)4 - SHOULDER INNOVATIONS, INC. (0001699350) (Issuer)
- SECSEC Form EFFECT filed by Shoulder Innovations Inc.EFFECT - SHOULDER INNOVATIONS, INC. (0001699350) (Filer)
- INSIDERNew insider Osborne Jonathan E. claimed ownership of 60,355 shares (SEC Form 3)3 - SHOULDER INNOVATIONS, INC. (0001699350) (Issuer)
- SECShoulder Innovations Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits8-K - SHOULDER INNOVATIONS, INC. (0001699350) (Filer)
- PRShoulder Innovations Promotes Jon Osborne to Chief Commercial OfficerGRAND RAPIDS, Mich., Aug. 10, 2026 /PRNewswire/ -- Shoulder Innovations, Inc. (Shoulder Innovations, or the company) (NYSE:SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today announced the promotion of Jon Osborne to Chief Commercial Officer, effective August 6, 2026. Mr. Osborne, who most recently served as Vice President of Commercial Development, will now have responsibility for all elements of Shoulder Innovations' commercial organization and will work closely with its Customer Experience and Medical Education team to execute the company's commercial strategy.
- SECAmendment: SEC Form SCHEDULE 13D/A filed by Shoulder Innovations Inc.SCHEDULE 13D/A - SHOULDER INNOVATIONS, INC. (0001699350) (Subject)
- INSIDERLarge owner Gilde Healthcare Holding B.V. sold $213,479 worth of shares (9,433 units at $22.63) (SEC Form 4)4 - SHOULDER INNOVATIONS, INC. (0001699350) (Issuer)
- SECSEC Form S-3 filed by Shoulder Innovations Inc.S-3 - SHOULDER INNOVATIONS, INC. (0001699350) (Filer)
- SECSEC Form 10-Q filed by Shoulder Innovations Inc.10-Q - SHOULDER INNOVATIONS, INC. (0001699350) (Filer)
- SECShoulder Innovations Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - SHOULDER INNOVATIONS, INC. (0001699350) (Filer)
- PRShoulder Innovations Reports Second Quarter 2026 Financial Results and Raises Full Year OutlookGenerates First Half 2026 Revenue Growth of 60%GRAND RAPIDS, Mich., Aug. 6, 2026 /PRNewswire/ -- Shoulder Innovations, Inc. (Shoulder Innovations, or the company) (NYSE:SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today reported financial results for the second quarter ended June 30, 2026. Second Quarter Financial HighlightsGenerated net revenue of $17.2 million in the second quarter, a 56% increase over the second quarter of 2025Achieved gross margin of 78.3% for the second quarter compared to 76.2% for the second quarter of 2025Increased average sell
SI FAQ
7 questionsWhat does Shoulder Innovations Inc. do?
Silvergate Capital Corporation operates as a bank holding company for Silvergate Bank that provides banking products and services to business and individual clients in the United States and internationally. The company accepts deposit products, including interest and noninterest bearing demand accounts, money market and savings accounts, and certificates of deposit accounts. Its loan products comprise one-to-four family real estate loans, multi-family real estate loans, commercial real estate loans, construction loans, commercial and industrial loans, mortgage warehouse loans, and reverse...Where does SI stock trade?
Shoulder Innovations Inc. (SI) is listed on NYSE.What sector and industry is SI in?
Shoulder Innovations Inc. operates in the Health Care sector, Medical/Dental Instruments industry.When did Shoulder Innovations Inc. go public?
Shoulder Innovations Inc. (SI) completed its IPO in 2025.What are analysts saying about SI?
Shoulder Innovations Inc. has had 8 recent analyst actions on file. The most recent action was from UBS: Buy with a $2700.00 price target on 2026-07-28.What companies are similar to SI?
Notable peers in the same industry include SYK (Stryker Corporation), MMM (3M Company), BSX (Boston Scientific Corporation), BDX (Becton Dickinson and Company), MDLN (Medline Inc.). Compare SI side-by-side with any of them on Quantisnow.How can I track SI on Quantisnow?
Quantisnow aggregates Shoulder Innovations Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow SI to receive live email and push alerts on every new disclosure.